MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2026 International Congress

    Clinical and Autonomic Correlates of Chronic Sialorrhea in Parkinson’s Disease: A Questionnaire-Based Study with Cluster Analysis of Autonomic and Dysphagia Burden

    S. Okusa, R. Okochi, Y. Sakai, T. Nukariya, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: To examine factors associated with drooling in patients with Parkinson’s disease (PD), patient awareness and perceptions of botulinum toxin therapy, and the relative contributions…
  • 2026 International Congress

    When Muscles Relax but Symptoms Persist: A Case of Dysfunctional Sensory-Motor Cortical Integration in Botulinum Toxin-Resistant Blepharospasm

    VD. Tkachenko, MZ. Makoeva (Moscow, Russian Federation)

    Objective: To present a case of blepharospasm (BSP) with objective response to serial botulinum toxin injections but persistent subjective symptoms, highlighting the role of sensory…
  • 2026 International Congress

    A Digital Toolkit for Movement Disorders Clinicians

    A. Lin, J. Patino, B. Talavera, Z. Yu, G. Brawerman, A. Koppanatham, C. Terrazas-Gamboa, A. Mahajan (Cincinnati, USA)

    Objective: To evaluate early adoption and real-world usage patterns of a digital toolkit designed for movement disorders clinicians Background: Movement disorders clinicians rely on multiple…
  • 2026 International Congress

    Rhythmic circular stump movements after traumatic amputation: jumping stump syndrome with rapid remission after botulinum toxin type A

    P. Muangsiri, P. Chairangsaris (Bangkok, Thailand)

    Objective: To describe the clinical phenomenology and treatment response of post-traumatic jumping stump syndrome following above-knee amputation. Background: Peripherally induced movement disorders are an underrecognized…
  • 2026 International Congress

    Outcomes of a new electromyography-guided botulinum toxin injection clinic for medication-refractory upper limb tremor

    R. Hoe, S. Neo (Singapore, Singapore)

    Objective: To describe the outcomes of a new electromyography (EMG)-guided botulinum toxin (BT) clinic for treatment of tremor in our center. Background: Tremor is often…
  • 2025 International Congress

    Hemimasticatory Spasm Secondary to an Anterior Inferior Cerebellar Artery Loop Treated with Botulinum Toxin Injection

    K. Kaneko, D. Gonzalez (Phoenix, USA)

    Objective: To present a case of hemimasticatory spasm (HMS) secondary to an anterior inferior cerebellar artery (AICA) loop treated with botulinum injection. Background: HMS is…
  • 2025 International Congress

    Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

    HS. Lee (Sacramento, USA)

    Objective: Botulinum toxin has been an effective and safe treatment option for hemifacial spasm. This is a report of 5 patients with successful treatment of…
  • 2025 International Congress

    Personalised Success: Evaluating Hemifacial Spasm Treatment with Goal Attainment Scale

    S. Maytharakcheep, O. Phokaewvarangkul, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To assess the effectiveness of botulinum toxin A (BoNTA) therapy in treating  hemifacial spasm (HFS) patients using Goal Attainment Scale (GAS). Background: HFS is…
  • 2025 International Congress

    Role of the other babinski sign in hemifacial spasm

    YC. Chen, SL. Chen (Taichung, Taiwan)

    Objective: To investigate the role of the “Other Babinski Sign” in differentiating HFS from blepharospasm and to determine its prevalence in HFS patients. Background: The…
  • 2025 International Congress

    Botulinum toxin therapy in patients with Hemifacial spasm: beyond the treatment of motor symptoms.

    MB. Charra Castellani, MV. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Evaluate the quality of life and the presence of anxiety and depression in HFS patients and their behavior after botulinum toxin administration. Background: Hemifacial…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley